Bioxytran, Inc
BIXT· OTC
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001213900-13-002539
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $114.30K | $133.41K | $7.93K |
| Net Income | -$974.05K | -$466.92K | -$1.39M |
| EPS Diluted | -$0.01 | $0.00 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end